This article is more than 5 years old. Information may no longer be current.

Smith & Nephew showcases new knee replacement at AAOS

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Smith & Nephew announced the showcase of the Journey II Bi-Cruciate Stabilized knee replacement at this year’s American Academy of Orthopaedic Surgeons meeting in Chicago.

Made from Smith & Nephew’s Verilast Technology, the Journey II Bi-Cruciate Stabilized (BCS) knee sets a new standard in knee implant performance by restoring more normal motion, according to a press release. Through the reproduction of both the shapes of the joint’s hard surfaces and the normal force behavior of the soft tissues, the soft tissue’s readjustment to new shapes and forces after surgery is minimized, helping to return the patient’s stride to its natural rhythm.

“The Journey II BCS knee takes knee performance beyond the current standards for fit and alignment and gives patients the complex motion, strength and stability of a human knee,” Gaurav Agarwal, president of Smith & Nephew, stated in a company press release. “You do not have to ask patients if it feels like a normal knee — you can see it in their gait and in their post-op x-rays. We redefined knee implant function when we launched the original Journey knee in 2005, and with Journey II BCS we have again outpaced traditional knee replacement technology.”